The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R., Wu, Z., Huang, F., Xia, H., Peters, M. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81053-3 · Cited by 1,596
Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide Synthase
Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman, M. C., & Moskowitz, M. A. (1994) · Science · doi:10.1126/science.7522345 · Cited by 1,565
The changing landscape of ischaemic brain injury mechanisms
Lee, J.-M., Zipfel, G. J., & Choi, D. W. (1999) · Nature · doi:10.1038/399a007 · Cited by 1,102
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909
Specific Coupling of NMDA Receptor Activation to Nitric Oxide Neurotoxicity by PSD-95 Protein
Sattler, R., Xiong, Z., Lu, W.-Y., Hafner, M., MacDonald, J. F., & Tymianski, M. (1999) · Science · doi:10.1126/science.284.5421.1845 · Cited by 834
Self-citationZhou, L., & Zhu, D.-Y. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.03.001 · Cited by 663
Self-citationMolecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury
Arundine, M., & Tymianski, M. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3319-x · Cited by 647
Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase
Nelson, R. J., Demas, G. E., Huang, P. L., Fishman, M. C., Dawson, V. L., Dawson, T. M., & Snyder, S. H. (1995) · Nature · doi:10.1038/378383a0 · Cited by 595
NMDA receptor pathways as drug targets
Kemp, J. A., & McKernan, R. M. (2002) · Nature Neuroscience · doi:10.1038/nn936 · Cited by 476
Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice
Dawson, V., Kizushi, V., Huang, P., Snyder, S., & Dawson, T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02479.1996 · Cited by 406
Bringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403
Mechanism of differential control of NMDA receptor activity by NR2 subunits
Gielen, M., Retchless, B. S., Mony, L., Johnson, J. W., & Paoletti, P. (2009) · Nature · doi:10.1038/nature07993 · Cited by 325
Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists
MUIR, K. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.12.002 · Cited by 312
Pathologically activated therapeutics for neuroprotection
Lipton, S. A. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2229 · Cited by 257
Chiavegatto, S., Dawson, V. L., Mamounas, L. A., Koliatsos, V. E., Dawson, T. M., & Nelson, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1277 · Cited by 210
Cui, H., Hayashi, A., Sun, H.-S., Belmares, M. P., Cobey, C., Phan, T., Schweizer, J., Salter, M. W., Wang, Y. T., Tasker, R. A., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1464-07.2007 · Cited by 205
The cost of cerebral ischaemia
Flynn, R. W. V., MacWalter, R. S. M., & Doney, A. S. F. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.031 · Cited by 204
Emerging treatments for stroke in humans
Koroshetz, W. J., & Moskowitz, M. A. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10020-1 · Cited by 189
Subcellular Localization and Characterization of Neuronal Nitric Oxide Synthase
Hecker, M., Mülsch, A., & Busse, R. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62041524.x · Cited by 147
Cao, J., Viholainen, J. I., Dart, C., Warwick, H. K., Leyland, M. L., & Courtney, M. J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407024 · Cited by 147
Formation of nNOS/PSD-95 PDZ dimer requires a preformed β-finger structure from the nNOS PDZ domain
Tochio, H., Mok, Y., Zhang, Q., Kan, H.-M., Bredt, D. S., & Zhang, M. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4148 · Cited by 135
Tanda, K., Nishi, A., Matsuo, N., Nakanishi, K., Yamasaki, N., Sugimoto, T., Toyama, K., Takao, K., & Miyakawa, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-19 · Cited by 135
Solution structure and backbone dynamics of the second PDZ domain of postsynaptic density-95
Tochio, H., Hung, F., Li, M., Bredt, D. S., & Zhang, M. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3350 · Cited by 101
Altered Interaction Between PSD‐95 and the NMDA Receptor Following Transient Global Ischemia
Takagi, N., Logan, R., Teves, L. M., Wallace, M. C., & Gurd, J. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740169.x · Cited by 99
Impairments in fear conditioning in mice lacking the nNOS genePreprint
Kelley, J. B., Balda, M. A., Anderson, K. L., & Itzhak, Y. (2009) · Learning & Memory · doi:10.1101/lm.1329209 · Cited by 77
Rothe, F., Canzler, U., & Wolf, G. L. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00373-4 · Cited by 67
Lea, P. M., Movsesyan, V. A., & Faden, A. I. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706219 · Cited by 65
Quintana, E., Hernández, C., Alvarez, A. M., Esplugues, J. V., & Barrachina, M. D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0596fje · Cited by 25
Gállego, J., Muñóz, R., & Martínez‐Vila, E. (2009) · Cerebrovascular Diseases · doi:10.1159/000200445 · Cited by 12
Cited by
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Fricker, M., Tolkovsky, A. M., Borutaite, V., Coleman, M., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,108
Excitotoxicity and stroke: Identifying novel targets for neuroprotection
Lai, T. W., Zhang, S., & Wang, Y. T. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.006 · Cited by 1,106
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Self-citationPathogenic mechanisms following ischemic stroke
Khoshnam, S. E., Winlow, W., Farzaneh, M., Farbood, Y., & Moghaddam, H. F. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2938-1 · Cited by 621
Metadata
- Authors
- Zhou, L., Li, F., Xu, H.-B., Luo, C.-X., Wu, H.-Y., Zhu, M.-M., Lu, W., Ji, X., Zhou, Q.-G., & Zhu, D.-Y.
- Venue
- Nature Medicine
- Published
- 2010-11-21
- Volume
- 16
- Issue
- 12
- Pages
- 1439-1443
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2097497116
- Cited by
- 414
- References
- 31
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.